The vial says “research use only, not for human consumption.” That sentence is not a formality, and it is not a technicality that clinicians can reason their way around. It is the reason the product could be shipped to you without a prescription.
The three tiers, and what separates them
Approved drug. Manufactured under cGMP, tested and released against a specification, identity and potency verified, sterile and endotoxin-controlled, with a defined shelf life and a recall pathway. It reaches a patient through a pharmacy against a prescription.
Compounded preparation. Made by a 503A pharmacy for an identified patient, or by a registered 503B outsourcing facility which must meet cGMP and is FDA-inspected. Legitimate compounding requires an eligible substance — a component of an approved drug, an entry on the FDA’s 503A bulk drug substances list, or an applicable monograph.
Research chemical. Sold by a supplier that is not a pharmacy, labelled for laboratory use, with no requirement to verify identity, purity, sterility or endotoxin load for human administration — because human administration is expressly not the stated purpose.
The gap between the second and third tiers is not a matter of degree. It is the difference between a supply chain designed for patients and one designed to avoid being regulated as such.
What “research grade” actually leaves unverified
- Identity. Is the peptide in the vial the peptide on the label, and is the sequence correct?
- Purity. What proportion is the intended peptide, and what are the impurities? Truncated and deletion sequences are common in synthesis and are not inert.
- Quantity. Does the vial contain the stated mass? Underfill and overfill are both routinely reported.
- Sterility and endotoxin. The two that matter most for an injected product, and the two least likely to have been tested.
- Stability. Was it shipped and stored in conditions that preserve the molecule?
How to read a Certificate of Analysis properly
A COA is only as good as its provenance, and most of the ones circulating in this market fail on basic points:
- Does it name your lot? A COA for a different lot describes a different batch of material.
- Who performed the testing? A certificate produced by the seller is a marketing document. Independent laboratory testing is the standard.
- What methods were used? Identity and purity for a peptide need appropriate analytical methods; a single purity percentage with no method stated is not evidence.
- Was sterility and endotoxin tested? For an injectable, their absence from the certificate is the finding.
- Is it legible and verifiable? A PDF that cannot be traced back to the issuing laboratory is not a chain of custody.
The legal exposure is not only the pharmacy’s
Prescribers sometimes assume that ordering from a supplier transfers responsibility. It does not. Administering a research chemical to a patient is a clinical decision you made, documented in a chart with your name on it. Your malpractice carrier may take a view on unapproved compounds; it is worth reading the policy before you need to.
The defensible position is narrow and simple: use eligible substances from a legitimate 503A or 503B partner, verify the lot, document medical necessity, and obtain consent that accurately describes non-FDA-approved use.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Functional & Regenerative Medicine courses — live patients, expert faculty, and ongoing mentorship.
Questions for a supplier
- Are you a 503A pharmacy, a 503B outsourcing facility, or neither?
- On what basis is this substance eligible for compounding?
- May I see the independent COA for this specific lot?
- What are your sterility and endotoxin results?
- What is your recall procedure?
A supplier that cannot answer the first two questions has answered all five.
Frequently asked questions
What is the difference between research-grade and clinical-grade peptides?
Research-grade material is sold for laboratory use with no verification required for human administration. Clinically usable material comes from a legitimate compounding pathway with identity, purity and sterility controlled.
Are the peptides I buy online legal to use on patients?
Material labelled for research use is not intended or verified for human administration, and administering it is a clinical decision that sits with you.
Does a Certificate of Analysis make a research peptide safe?
Only if it is lot-specific, independently produced, method-transparent, and includes sterility and endotoxin results. Most do not.
Can a compounding pharmacy make any peptide I ask for?
No. The substance must be eligible under 503A rules, and most peptides discussed in wellness practice currently are not.
Are the peptides I am buying legal to use on patients?
It depends entirely on the source and the substance. Material sold as research grade is labelled for laboratory use, is not intended or verified for human administration, and is not dispensed by a pharmacy — administering it to a patient is a clinical decision that rests with you. Clinical grade peptides reach a patient through an approved drug or a legitimate 503A or 503B compounding pathway, and that pathway requires the substance itself to be eligible. If a supplier cannot tell you which of those two categories they are in, you have your answer.
Learn the sourcing layer
Module 2 of the Empire Peptide Therapy Certification covers pharmacy vetting, Certificates of Analysis and gray-market risk alongside the 503A and 503B framework. Pharmacists and compounding professionals can see the pharmacy track here.
Related: 503A vs 503B compounding.
